Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, T-Cell, Peripheral × sintilimab × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 18 Stomach Neoplasms 12 Colorectal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 6 Rectal Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Pancreatic Neoplasms 4 Esophageal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Triple Negative Breast Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Locally Advanced Cervical Carcinoma 2 Endometrial Neoplasms 2 Turcot syndrome 1 Thyroid Neoplasms 1 Squamous Cell Non-small Cell Lung Cancer 1 Spinocerebellar Degenerations 1 Sarcoma 1 Salivary Gland Malignant Neoplasms 1 Resectable NSCLC 1 Rare Tumor 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms 1 NSCLC 1 Microsatellite Stable Metastatic Colorectal Cancer 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1

Interventions

Cyclophosphamide 9 Prednisone 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 8 Doxorubicin 7 Vincristine 6 Azacitidine 5 fludarabine 3 belinostat 3 Gemcitabine 3 10-propargyl-10-deazaaminopterin 3 ruxolitinib 2 pembrolizumab 2 Lenalidomide 2 Dexamethasone 2 Brentuximab Vedotin 2 Biopsy 2 Bendamustine Hydrochloride 2 venetoclax 1 sodium-iodide symporter 1 sintilimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1 duvelisib 1 daratumumab 1 cemiplimab 1 calaspargase pegol 1 X-Rays 1 Watchful Waiting 1 VAP-cyclo protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04512534 2026-04-02

Sincerely20

Fudan University

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡